1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 14 DECEMBER 2015

Cancer Drug News 14 DECEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Leveraging Long-Term Data For Sustained Commercial Success
Industry Brief - Novartis To Begin Regulatory Submissions For Midostaurin In 2016
Industry Brief - Seattle Genetics To Move Novel ADC Into Phase III
Industry Brief - Genentech Reports Positive Pivotal Results From Venetoclax Phase II CLL Study
Industry Brief - Qinprezo Submitted To EMA For AML
Industry Brief - Milestone Triggered As FDA Approves Bendeka For CLL/NHL
Industry Trend Analysis - AbbVie Unlocking Imbruvica's Value
Industry Brief - Iclusig Phase III Trial Started In Second-Line Chronic Phase CML
Industry Brief - Amgen/Merck Enter Cancer Immunotherapy Collaboration
Industry Brief - Celgene/Astrazeneca Expand Immuno-Oncology Commitment
Industry Trend Analysis - Genomic Data Will Limit MM Market Size
Industry Brief - Lilly/Merck Expand Immuno-Oncology Collaboration
Industry Trend Analysis - Pfizer's Long-Term Oncology Position Not Limited By Xalkori
Industry Brief - Alecensa Launched In Japan
Industry Brief - HMP Initiates Fruquintinib Phase III Trial In NSCLC
Industry Brief - EMA Grants Orphan Drug Designation To Debio 1143
Industry Brief - Merck KGaA Initiates Two Phase III Studies Of Avelumab
Industry Brief - Merck KGaA Not to Pursue Evofosfamide Further In STS/PC
Industry Brief - XBiotech's Xilonix Meets Primary Endpoint In Phase III CRC Study
Industry Brief - Entrectinib Receives EU ODD For Neuroblastoma

Table Of Contents

Cancer Drug News 14 DECEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Cancer and Breast Cancer Statistics in Switzerland

  • February 2017
    138 pages
  • Cancer  

    Breast Cancer  

    Obesity  

  • Switzerland  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Endocrine Disease Statistics in the US

  • February 2017
    115 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Cancer Statistics

5 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.